Search Here

A new fluid biopsy’ technique has been developed to help those who exhibit symptoms but are yet to experience heart attack.

The ‘fluid biopsy’ technique, developed by researchers at Scripps Research Institute (TSRI) in California, US, will identify patients at high risk of suffering heart attack by analyzing specific cells that act as markers in the bloodstream.

The technique, which works by identifying circulating endothelial cells (CECs), has been successful in identifying symptoms in patients undergoing treatment for a recent heart attack.

“The goal of this research was to establish that these circulating endothelial cells can be detected reliably in patients following a heart attack and do not exist in healthy control group - which we have achieved,” said Peter Kuhn, associate professor and lead author in the press release.

“Our outcomes were so huge with respect to the solid controls that the clear next step is to survey the helpfulness of the test in recognizing patients throughout the unanticipated phases of a heart ambush,” he added.

Creators said the main aim of the paper was to build a proof that these flowing endothelial units possible might be located dependably in patients that exhibit heart attack symptoms.

“The goal of this paper was to establish evidence that these circulating endothelial cells can be detected reliably in patients following a heart attack and do not exist in healthy controls – which we have achieved,” said Kuhn.

“Our results were so significant relative to the healthy controls that the obvious next step is to assess the usefulness of the test in identifying patients during the early stages of a heart attack."

Endothelial units have been firmly associated with a hoisted heart strike attack when it flows in the blood stream. They are also accepted to enter the bloodstream when plaque advances.

The study has been published in the journal Physical Biology.